CRF Health Unveils TrialMax ConMed™ for Oncology Trials

Article

Applied Clinical Trials

The identification of concomitant medication poses specific challenges in oncology data reporting.

CRF Health, a global provider of electronic Clinical  Outcome Assessment (eCOA) solutions introduced a complete TrialMax® eCOA solution specifically for oncology clinical trials. The identification of concomitant medication poses specific challenges in oncology data reporting. To address this, CRF Health has incorporated its new TrialMax ConMed™ solution into the platform, allowing patients to report concomitant medication taken during a trial in real-time.

 

 

Read the full release here.

Newsletter

Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.

Recent Videos
Related Content
© 2025 MJH Life Sciences

All rights reserved.